sale
travel manag much like
yesterday host investor meet abiom cfo bob bowen ingrid ward
director ir manag note label expans last week like
expand shock patient popul protect pci like higher
view number likel conserv mean impella penetr
rate even lower like mid-singl digit believ signific
room growth manag usual talk rp japan still
bullish area intermedi perspect final compani lot
queue new patient pool technolog perspect believ
reflect stock
expand label increas tam like still conserv trip
manag time follow two label expans one shock one
protect pci say former may expand patient popul
latter like even higher base patient
view commentari conver usual lower
penetr rate impella util closer mid-singl digit rather
upper singl digit believ signific room go
rp japan like meaning contributor eventu manag indic
demand impella rp signific maintain governor usag
devic order ensur favor outcom similarli note like
disappoint wall street respect result japan work ensur excel
outcom enter critic new geographi said believ area
deliv signific growth eventu hundr million dollar collect
plenti pipelin although compani plenti plate
exist recent ad patient popul exam new subgroup
benefit impella new technolog could meaning expand total
address market come year area includ stemi vt
ablat along btr devic believ areas/
product incorpor stock price point though could needl
move revenu perspect caution though fairli earli
stock anticip get typic valuat pushback
note certainli acknowledg viewpoint simpli see mani larg
cap med tech name growth profil top- bottom line monopoli
posit keep us construct name continu encourag investor
start build posit
develop manufactur circulatori support devic
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
yesterday host investor meet abiom cfo bob bowen director
investor relat ingrid ward mani meet focus last week announc
abiom label shock protect pci patient expand remind last
week fda expand shock label includ cardiomyop patient well elimin
languag protect pci patient includ depress eject fraction
complex pci patient eject fraction factor compani maintain market size
shock patient protect pci listen manag
meet indic clearli market expand
respect shock compani believ reason new expand label
increas market couch statement say still learn
train educ new area said use figur
time lead us domest shock patient target lower
compani penetr rate impella shock
case last year import note new shock patient estim
still conserv number view potenti group larger
given mani heart failur patient unit state compani
current asp domest opportun
next sever quarter anticip shock larger growth driver impella
one driver nation csi cardiogen shock initi
state goal reach citi around current citi
implement initi start detroit program clearli earli inning
deliv strong util impella addit call action occur
tct late last year also meaning impact anticip continu
contribut come quarter well
beyond shock manag note expect label expans protect pci
profound effect patient popul still estim
shock group compani quantifi potenti impact assum
would rais patient popul mean penetr
impella group closer rather around believ even
elev patient popul follow label expans still conserv overal believ
domest protect pci market opportun like north
given light penetr rate categori actual closer mid-singl digit
consider room grow come year still convers alway turn
new driver compani manag note demand rp roughli patient
 though conserv estim remain robust sell
devic site target anticip quarter billion dollar
domest market soid growth contributor come quarter year
look outsid manag note believ strength seen germani
past coupl quarter durabl sourc acceler perform realli
stem shock ii studi result releas year ago demonstr
balloon pump realli work certainli believ german market
grow forev perform penetr rate
consequ anticip geographi remain strong contributor next coupl
sever year
one geographi investor need realist expect japan manag
reiter expect disappoint wall street respect new geographi
go quit slow train physician order ensur strong outcom given abiom
label japan shock expans protect pci like coupl year away
make sens go slow sick patient ensur clinician success
outcom suspect typic conserv respect japan
page
caution investor expect much especi earli day new geographi
longer term patient target japan equat anoth
market opportun compani though may conserv figur well
still opportun broaden usag impella first get
opinion ton investor interest stemi patient popul stemi stand
st elev myocardi infarct differ type heart attack shock
patient investor accustom hear howev impella abl reduc
patient reprofus injuri follow mi could bear signific benefit longer term
manag indic feasibl studi half enrol total patient
continu expect complet octob year potenti
finish sooner follow studi day consid time collect data
expect submiss earli calendar potenti earlier
assum studi posit compani move pivot studi patient
popul manag provid detail time trial design number patient
etc believ commenc next year potenti compani could address
patient popul stemi patient year
would repres anoth market opportun impella inde work treat
patient believ anyth stock stemi patient point
lastli certainli least new area assess impella new
product develop indic perspect certainli far impella
use ventricular tachycardia case fairli small number right allow
clinician take time perform ablat sure get right locat
maxim outcom requir chang approach treat vt part
clinician ten hundr thousand procedur perform
year mean could signific opportun eventu
compani continu work product bridge-to-recoveri btr product
along ecp though ease-of-us upgrad time devic
avail product design treat differ set patient specif
btr product design treat class heart failur patient option
want lvad hope bring patient back baselin current heart
failur statu would massiv benefit patient occur even slow
progress hf would huge benefit least non-ischem
hf patient repres anoth btr inde
product work collect believ either work technolog
amount nearli number like conserv compani
penetr signific runway growth come year
beyond top-lin get lion share investor attent compani continu
make progress leverag oper margin rais outlook key metric
fiscal basi point upsid realli come improv sale rep
product manag mention roughli impella util unsupervis
initi rep compani continu add sale rep roughli per quarter
anticp dynam persist encourag organ improv oper
margin believ consider room go come year final
compani tax rate clearli go fall fiscal begin april year
go anoth meaning sourc earn power stori overal certainli
acknowledg premium valuat stock simpli see mani larg cap
med tech name capabl grow top- bottom line elev clip
compar rest peer consequ view premium valuat warrant
continu encourag investor start build posit compel technolog provid
page
